Sort
16,179 grants matching “malaria”
Transgenic Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture
$1,000,000Peter F. Billingsley · Sanaria, Inc. · R44 · FY2013 · AI
Universal Attenuated Sporozoite Vaccine and Challenge System
$1,000,000Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2012 · AI
CARIBBEAN PRIMATE RESEARCH CENTER PROGRAM
$1,000,000Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · P40 · FY2008 · RR
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera.
$1,000,000Agenor Mafra-Neto · Isca Technologies, Inc. · SB1 · FY2023 · AI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine
$1,000,000Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2017 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine
$1,000,000Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2021 · AI
Plasmodium vivax recombinant CS protein vaccine for malaria
$1,000,000B. Kim Lee Sim · Protein Potential, Llc · R44 · FY2010 · AI
Genomic and environmental risk factors for cardiometabolic disease in Africans
$1,000,000Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2015 · HG
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera.
$1,000,000Agenor Mafra-Neto · Isca Technologies, Inc. · SB1 · FY2022 · AI
A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products
$1,000,000Peter F. Billingsley · Sanaria, Inc. · R44 · FY2021 · AI
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.
$1,000,000Nhi Khuong · Lumen Bioscience, Inc. · R42 · FY2023 · AI
IMPROVING MANUFACTURING AND POTENCY OF CRYOPRESERVED MALARIA SPOROZOITE VACCINE
$1,000,000Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2012 · AI
IMPROVING MANUFACTURING AND POTENCY OF CRYOPRESERVED MALARIA SPOROZOITE VACCINE
$1,000,000Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2013 · AI
Enabling Toxoplasma gondii Kinome Directed Drug Discovery
$1,000,000Reena Zutshi · Luceome Biotechnologies, Llc · R44 · FY2023 · AI
Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib
$1,000,000Richard W Scott · Polymedix, Inc, · R44 · FY2012 · AI
Plasmodium vivax recombinant CS protein vaccine for malaria
$1,000,000B. Kim Lee Sim · Protein Potential, Llc · R44 · FY2011 · AI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine
$1,000,000Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2018 · AI
Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria
$1,000,000Vinayak S Joshi · Visionquest Biomedical Inc · R44 · FY2020 · AI
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$1,000,000Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2019 · AI
Transgenic Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture
$1,000,000Peter F. Billingsley · Sanaria, Inc. · R44 · FY2012 · AI
Enabling Toxoplasma gondii Kinome Directed Drug Discovery
$1,000,000Reena Zutshi · Luceome Biotechnologies, Llc · R44 · FY2024 · AI
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.
$1,000,000Nhi Khuong · Lumen Bioscience, Inc. · R42 · FY2021 · AI
Long Lasting Organic Semiochemical Formulation to Effectively Manage Blood Sucking Diptera.
$1,000,000Agenor Mafra-Neto · Isca Technologies, Inc. · SB1 · FY2024 · AI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites
$1,000,000Sumana Chakravarty · Sanaria, Inc. · U44 · FY2025 · AI
Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib
$1,000,000Richard W Scott · Fox Chase Chemical Diversity Center, Inc · R44 · FY2014 · AI